← Back to all trials
Active Not Recruiting
NCT05608642
Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment
Conditions: Medication Overuse Headache
Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 45
Sponsor: Diskapi Teaching and Research Hospital
Location: Turkey
Summary
Medication overuse headache is the chronicity of headaches, which occurs more than 15 days a month, as a result of frequent use of painkillers, opioids or migraine attack drugs (ergotamine, triptan) in individuals with pre-existing primary headache disease.In the treatment of this headache, two ways can be followed as slow drug discontinuation or sudden drug discontinuation.
The most commonly used method is the sudden discontinuation of the overused analgesic agent, the initiation of prophylactic treatment, and then the application of bridge therapy for 6-10 days.
Intravenous hydration, steroids, antiemetics, neuroleptic drugs and local anesthetic drugs such as lidocaine can be used in bridge treatment.
Eligibility Criteria
Inclusion Criteria:Medication overuse headacheChronic migraineExclusion Criteria:Other headaches will not accompany (tension-type headache, cluster...)PregnancyEpilepsiaHeart diseaseBradikardiaHypertensionDiabetes mellitus
Source: ClinicalTrials.gov (NCT05608642). StuddyBuddy aggregates publicly available trial information.